Spotlight
Interventional Cardiology
Interventional Cardiology

Learn about Interventional Cardiology and the subspecialty trained cardiologists at Wake Forest Baptist Health's Heart Center.

MORE

Profile

Sanjay Kumar Gandhi, M.D.

Video Profile
Request An Appointment

Sanjay Kumar Gandhi, M.D.

Associate Professor, Cardiology
Contact Information
Appointment:
336-716-6674
Office:
336-716-2095
Fax:
336-716-9188
Clinical Specialties
Pericardial Diseases, Structural Heart Disease, PFO/ASD Closure, Angioplasty, Cardiology (clinical), Cardiology (interventional)
Education & Training
  BAEmory University1988
  MDVanderbilt University School of Medicine1992
ResidencyInternal MedicineVanderbilt Univ Medical Center1995
FellowshipVanderbilt University School of Medicine1996
  Wake Forest University1999
Board Certifications
American Board of Internal Medicine , Cardiovascular Disease
American Board of Internal Medicine , Interventional Cardiology
American Board of Internal Medicine , Internal Medicine
NPI Number
1295710275
Sanjay Kumar Gandhi, M.D.

Video Profile
Request An Appointment

Sanjay Kumar Gandhi, M.D.

Associate Professor, Cardiology
Contact Information
Appointment:
336-716-6674
Office:
336-716-2095
Fax:
336-716-9188
Recent Publications
Schafer PE, Sacrinty MT, Cohen DJ, Kutcher MA, Gandhi SK, Santos RM, Little WC, Applegate RJ. Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice. Circ Cardiovasc Qual Outcomes. 2011; 4(4):408-415.

Manogue MR, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Turner SJ, Applegate RJ. Bleeding avoidance strategy: transition from femoral to radial artery as the preferred access for cardiac procedures. The Wake Forest academic medical center experience [abstract]. J Am Coll Cardiol. 2011; 57(14 Suppl 1):E1057.

Schafer P, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, Applegate RJ. Cost effectiveness of drug-eluting stents versus bare metal stents in clinical practice: effect of stent length and diameter [abstract]. J Am Coll Cardiol. 2011; 57(14 Suppl 1):E1184.

Turner S, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Manogue MR, Applegate RJ. Cath lab utilization during transition to the radial artery as preferred access: the Wake Forest academic medical center experience [abstract]. J Am Coll Cardiol. 2011; 57(14 Suppl):E1269.

Crowder JS, Hubble MW, Gandhi S, McGinnis H, Zelman S, Bozeman W, Winslow J. Prehospital administration of tenecteplase for ST-segment elevation myocardial infarction in a rural EMS system. Prehosp Emerg Care. 2011; 15(4):499-505.

Schafer PE, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Cecile AC, Applegate RJ. Resource utilization for propensity matched radial and femoral catheterization and intervention [abstract]. J Am Coll Cardiol. 2011; 58(20 Suppl B):B146-B147.

Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes. J Invasive Cardiol. 2010; 22(6):266-270.

Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes. Circ Cardiovasc Interv. 2009; 2():35-42.

Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. 3-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol Intv. 2009; 2(3):231-239.

Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. Three-year comparison of drug-eluting versus bare metal stents [abstract]. J Am Coll Cardiol. 2009; 53(10 Suppl 1):A353.

Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Clinical outcomes of bare metal stents versus drug-eluting stents target vessel revascularization: evidence for a high-risk bare metal stent cohort [abstract]. J Am Coll Cardiol. 2009; 53(10 Suppl 1):A317-A318.

Santos RM, Sacrinty MJ, Kutcher MA, Gandhi SK, Little WC, Applegate RJ. Drug-eluting stent versus bare metal stent use in patients with chronic kidney disease [abstract]. J Am Coll Cardiol. 2009; 53(10 Suppl 1):A393-A394.

Applegate R, Sacrinty M, Little W, Gandhi S, Kutcher M, Santos R. Prognostic implications of vascular complications following PCI. Catheter Cardiovasc Interv. 2009; 74(1):64-73.

Kumar R, Gandhi SK, Little WC. Acute heart failure with preserved systolic function. Crit Care Med. 2008; 36(1 Suppl):S52-S56.

Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC. 'Off-label' stent therapy. J Am Coll Cardiol. 2008; 51(6):607-614.

Applegate RJ, Graham SH, Gandhi SK, Kutcher MA, Sacrinty MT, Santos RM, Little WC. Culprit vessel PCI versus traditional cath and PCI for STEMI. J Invasive Cardiol. 2008; 20(5):224-228.

Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Drug-eluting stents versus bare metal stents in saphenous vein grafts at 2 years [abstract]. J Am Coll Cardiol. 2008; 51(10 Suppl B):B78.

Gandhi SK, Kay JD, Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Little WC. Drug-eluting stents for ST elevation myocardial infarction: evidence for benefit at two years [abstract]. J Am Coll Cardiol. 2008; 51(10 Suppl B):B1.

Graham SH, Applegate RJ, Gandhi SK, Sacrinty MT, Baki TT, Santos RM, Little WC, Kutcher MA. Culprit vessel primary percutaneous coronary intervention for ST elevation myocardial infarction shorter door to balloon time [abstract]. J Am Coll Cardiol. 2008; 51(10 Suppl B):B61.

Turner SJ, Ketch TR, Gandhi SK, Sane DC. Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes. Am Heart J. 2008; 155(5):806-816.

Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, Little WC. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. J Am Coll Cardiol Intv. 2008; 1(3):317-326.

Applegate RJ, Sacrinty M, Kutcher M, Santos R, Gandhi S, Little W. Late outcomes of drug-eluting versus bare meta stents in saphenous vein grafts: propensity score analysis. Catheter Cardiovasc Interv. 2008; 72(1):7-12.

Applegate RJ, Sacrinty MT, Little WC, Santos RM, Gandhi SK, Kutcher MA. Incidence of coronary stent thrombosis based on academic research consortium definitions. Am J Cardiol. 2008; 102(6):683-688.

Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Prognostic implications of post percutaneous coronary intervention vascular complications [abstract]. Am J Cardiol. 2008; 102(8A Suppl):9i.

Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death. Am J Cardiol. 2007; 99(3):333-338.

Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Kahl FR, Little WC. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaeous coronary intervention using thrombin hemostatic patch-facilitated manual compression. J Invasive Cardiol. 2007; 19(4):164-170.

Newsome LT, Kutcher MA, Gandhi SK, Prielipp RC, Royster RL. A protocol for the perioperative management of patients with intracoronary drug-eluting stents [newsletter article]. APSF [Anesthesia Patient Safety Foundation] Newsl. 2007; 21(4):81-82.

Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Vascular complications following cardiac catheterization and coronary intervention 1998-2005: influence of gender [abstract]. J Am Coll Cardiol. 2007; 49(9 Suppl):193A.

Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Kahl FR, Santos RM, Little WC. Vascular complications in women after catheterization and percutaneous coronary intervention 1998-2005. J Invasive Cardiol. 2007; 19(9):369-374.

Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Vascular complications 1998-2007: evidence for better outcomes [abstract]. Am J Cardiol. 2007; 100(8 Suppl 1):6L.

Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Baki TT, Gandhi SK, Little WC. Off-label DES vs. BMS treatment: outcomes at 2 years [abstract]. Am J Cardiol. 2007; 100(8 Suppl 1):159L.

Call J, Sacrinty M, Applegate R, Little W, Santos R, Baki T, Gandhi S, Kahl F, Kutcher M. Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy. J Invasive Cardiol. 2006; 18(10):469-474.

Applegate RJ, Upadhya B, Little WC, Xenakis M, Gandhi SK, Baki TT, Kahl FR, Kutcher MA. Late outcomes after intervention of vein grafts in diabetics with abciximab use. Int J Cardiol. 2006; 111(1):136-141.

Applegate RJ, Kutcher MA, Little WC, Sacrinty MT, Gandhi SK, Baki TT, Santos RM. Vascular complications after cath and percutaneous coronary intervention: thrombin hemostatic patch versus manual compression [abstract]. Circulation. 2006; 114(18 Suppl):II-392.

Applegate RJ, Grabarczyk MA, Sane DC, Sacrinty MT, Goodin JE, Statonk GS, Baki TT, Gandhi SK, Kutcher MA, Little WC. PCI with and without abciximab after upstream eptifibatide use: outcomes in high-risk patients. J Invasive Cardiol. 2006; 18(12):604-613.

Applegate RJ, Kutcher MA, Little WC, Sacrinty MT, Gandhi SK, Baki TT, Santos RM. Vascular complications after cath and percutaneous coronary intervention: thrombin hemostatic patch versus manual compression [abstract]. Am J Cardiol. 2006; 98(8A Suppl):184M-185M.

Applegate RJ, Kutcher MA, Little WC, Sacrinty MT, Gandhi SK, Baki TT, Santos RM. Drug-eluting stent treatment of patients with myocardial infarction--efficacy and safety at nine months [abstract]. Am J Cardiol. 2006; 98(8A Suppl):75M.

Leonard JC, Sacrinty MT, Applegate RJ, Little WC, Baki TT, Gandhi SK, Santos RM, Kutcher MA. Timing of intervention in non-ST-segment elevation myocardial infarctions: nine month outcomes [abstract]. Am J Cardiol. 2006; 98(8A Suppl):80M-81M.
All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Sanjay Kumar Gandhi, M.D.

Video Profile
Request An Appointment

Sanjay Kumar Gandhi, M.D.

Associate Professor, Cardiology
Contact Information
Appointment:
336-716-6674
Office:
336-716-2095
Fax:
336-716-9188

 

Back To Top
Last Updated 5/3/2012
Quick Reference
Request an Appointment
New Patients
336-716-WAKE
888-716-WAKE
Existing patients may contact the clinic directly.
Find a Doctor

e.g., "allergy," "diabetes"

US News Best Hospital AwardANCC Magnet Association AwardBest Doctors 2011-2012 AwardConsumer Choice #1 Award 2011-2102US News Best Medical Schools 2011 Award

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.